ARIPIPRAZOLE

ARIPIPRAZOLE was reported 123307 times

ARIPIPRAZOLE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BANKRUPTCY 387 0.8600
1 COMPULSIVE HOARDING 245 0.7632
2 GAMBLING DISORDER 2063 0.7629
3 COMPULSIVE SEXUAL BEHAVIOUR 603 0.7444
4 SHOPLIFTING 184 0.6643
5 BLOOD PROLACTIN ABNORMAL 571 0.6616
6 DIVORCED 282 0.6395
7 HOMELESS 274 0.6157
8 ANOSOGNOSIA 469 0.6107
9 COMPULSIVE SHOPPING 1170 0.5682
10 RHESUS INCOMPATIBILITY 68 0.5620
11 GAMBLING 529 0.4537
12 STUBBORNNESS 174 0.4037
13 PSYCHOSEXUAL DISORDER 111 0.3841
14 THEFT 241 0.3624
15 SCHIZOAFFECTIVE DISORDER 584 0.3272
16 ANTIPSYCHOTIC DRUG LEVEL BELOW THERAPEUTIC 216 0.3126
17 TRICHOTILLOMANIA 172 0.2935
18 SEXUALLY TRANSMITTED DISEASE 125 0.2874
19 HYPERSEXUALITY 461 0.2521
20 PSYCHOTIC SYMPTOM 502 0.2430
21 PERSONAL RELATIONSHIP ISSUE 161 0.2407
22 DERMATILLOMANIA 143 0.2399
23 OCULOGYRIC CRISIS 513 0.2388
24 DELUSIONAL DISORDER, PERSECUTORY TYPE 96 0.2291
25 OBSESSIVE-COMPULSIVE DISORDER 1815 0.2259
26 AKATHISIA 3070 0.2248
27 ORTHOSTATIC HYPERTENSION 123 0.2110
28 DELUSION OF GRANDEUR 90 0.2004
29 NEUROPSYCHIATRIC SYMPTOMS 178 0.1971
30 DRUG MONITORING PROCEDURE INCORRECTLY PERFORMED 130 0.1961
31 DISTURBANCE IN SOCIAL BEHAVIOUR 454 0.1925
32 PSYCHIATRIC DECOMPENSATION 365 0.1866
33 DISINHIBITION 281 0.1744
34 IMPULSE-CONTROL DISORDER 358 0.1738
35 SCHIZOPHRENIA 2085 0.1714
36 LOSS OF EMPLOYMENT 517 0.1710
37 COGWHEEL RIGIDITY 176 0.1676
38 BINGE EATING 172 0.1594
39 ANTIPSYCHOTIC DRUG LEVEL DECREASED 84 0.1582
40 NEUROLEPTIC MALIGNANT SYNDROME 1723 0.1451
41 METABOLIC SYNDROME 238 0.1448
42 POOR PERSONAL HYGIENE 74 0.1434
43 IMPULSIVE BEHAVIOUR 536 0.1427
44 SEXUALLY INAPPROPRIATE BEHAVIOUR 65 0.1395
45 BLUNTED AFFECT 102 0.1382
46 PARKINSONISM 1320 0.1352
47 EMOTIONAL POVERTY 232 0.1323
48 PERSECUTORY DELUSION 320 0.1282
49 LIBIDO INCREASED 245 0.1207
50 SOCIAL ANXIETY DISORDER 76 0.1157
51 COMPULSIONS 77 0.1156
52 PARKINSONIAN GAIT 71 0.1138
53 HALLUCINATION, AUDITORY 1791 0.1126
54 ECONOMIC PROBLEM 1634 0.1077
55 SUSPICIOUSNESS 75 0.1065
56 OROMANDIBULAR DYSTONIA 77 0.1056
57 METABOLIC DISORDER 606 0.1042
58 HYPERPROLACTINAEMIA 671 0.1034
59 ANTIPSYCHOTIC DRUG LEVEL ABOVE THERAPEUTIC 92 0.1033
60 SOLILOQUY 89 0.1029
61 TARDIVE DYSKINESIA 2905 0.1029
62 SEXUAL DYSFUNCTION 1204 0.1026
63 PSYCHOTIC DISORDER 2933 0.0992
64 CATATONIA 514 0.0978
65 MANIA 1596 0.0969
66 DYSTONIA 1864 0.0960
67 SEDATION COMPLICATION 240 0.0940
68 SELF-DESTRUCTIVE BEHAVIOUR 81 0.0929
69 DELUSION 1443 0.0928
70 BREECH PRESENTATION 116 0.0921
71 TONGUE MOVEMENT DISTURBANCE 76 0.0888
72 HYPOMANIA 326 0.0886
73 SEDATION 2298 0.0877
74 SUPPRESSED LACTATION 65 0.0866
75 ANTIPSYCHOTIC DRUG LEVEL INCREASED 239 0.0848
76 BIPOLAR I DISORDER 186 0.0847
77 EXTRAPYRAMIDAL DISORDER 2084 0.0838
78 PATHOLOGICAL GAMBLING 137 0.0825
79 BLOOD PROLACTIN INCREASED 381 0.0807
80 STEREOTYPY 76 0.0806
81 PLEUROTHOTONUS 72 0.0796
82 SALIVARY HYPERSECRETION 777 0.0776
83 TORTICOLLIS 164 0.0773
84 HOSTILITY 196 0.0770
85 HALLUCINATIONS, MIXED 322 0.0765
86 GAZE PALSY 129 0.0757
87 VICTIM OF CRIME 91 0.0734
88 SUBSTANCE USE 114 0.0730
89 PERSONALITY DISORDER 190 0.0725
90 OBESITY 1154 0.0724
91 GESTATIONAL DIABETES 334 0.0700
92 TIC 364 0.0667
93 HYPERPHAGIA 263 0.0659
94 SOCIAL AVOIDANT BEHAVIOUR 381 0.0658
95 ACUTE PSYCHOSIS 162 0.0654
96 BIPOLAR DISORDER 702 0.0645
97 DROOLING 439 0.0635
98 PSYCHOTIC BEHAVIOUR 63 0.0620
99 REDUCED FACIAL EXPRESSION 62 0.0611
100 MUTISM 88 0.0606
101 DYSKINESIA 2435 0.0599
102 SUICIDE ATTEMPT 3625 0.0597
103 OBSESSIVE THOUGHTS 106 0.0588
104 CONSCIOUSNESS FLUCTUATING 61 0.0584
105 PSYCHOMOTOR RETARDATION 164 0.0583
106 PRIAPISM 193 0.0559
107 PERSONALITY CHANGE 519 0.0558
108 DIABETIC COMA 156 0.0557
109 FLAT AFFECT 128 0.0552
110 HOMICIDAL IDEATION 223 0.0550
111 TACHYPHRENIA 188 0.0542
112 MUSCLE RIGIDITY 647 0.0540
113 GALACTORRHOEA 347 0.0540
114 INAPPROPRIATE AFFECT 84 0.0530
115 BRUXISM 285 0.0528
116 IMPRISONMENT 93 0.0526
117 RESTLESSNESS 1922 0.0525
118 PARANOIA 901 0.0522
119 LOGORRHOEA 183 0.0519
120 JUDGEMENT IMPAIRED 74 0.0509
121 FEELING GUILTY 67 0.0508
122 PSYCHIATRIC SYMPTOM 371 0.0502
123 DEPRESSIVE SYMPTOM 175 0.0496
124 POSTURE ABNORMAL 161 0.0494
125 AFFECTIVE DISORDER 381 0.0484
126 STUPOR 153 0.0476
127 INTENTIONAL SELF-INJURY 944 0.0467
128 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 104 0.0465
129 DISABILITY 912 0.0461
130 SOCIAL PROBLEM 189 0.0456
131 DYSLIPIDAEMIA 231 0.0454
132 SUICIDAL IDEATION 4145 0.0452
133 EOSINOPHIL COUNT DECREASED 107 0.0449
134 APATHY 655 0.0449
135 TYPE 1 DIABETES MELLITUS 268 0.0445
136 THINKING ABNORMAL 825 0.0442
137 REFUSAL OF TREATMENT BY PATIENT 288 0.0441
138 INSULIN RESISTANCE 91 0.0437
139 SELF-INJURIOUS IDEATION 183 0.0436
140 TRISMUS 225 0.0435
141 PSYCHOMOTOR SKILLS IMPAIRED 114 0.0435
142 DIABETIC COMPLICATION 109 0.0428
143 TONGUE BITING 88 0.0426
144 ENURESIS 171 0.0423
145 TYPE 2 DIABETES MELLITUS 1408 0.0418
146 PHYSICAL ASSAULT 87 0.0416
147 MENTAL DISORDER 1808 0.0415
148 JAUNDICE NEONATAL 78 0.0412
149 DIABETIC NEUROPATHY 204 0.0412
150 MEGACOLON 64 0.0407
151 THERAPEUTIC PRODUCT EFFECT VARIABLE 158 0.0407
152 SEROTONIN SYNDROME 769 0.0400
153 EUPHORIC MOOD 409 0.0399
154 EATING DISORDER 848 0.0398
155 INCREASED APPETITE 760 0.0397
156 AGGRESSION 1978 0.0395
157 PARADOXICAL DRUG REACTION 144 0.0391
158 NARCOLEPSY 73 0.0386
159 ABNORMAL BEHAVIOUR 1518 0.0383
160 TREATMENT NONCOMPLIANCE 2090 0.0382
161 ALCOHOL ABUSE 102 0.0381
162 STARING 92 0.0380
163 SUICIDAL BEHAVIOUR 156 0.0375
164 PSYCHOMOTOR HYPERACTIVITY 621 0.0374
165 DRUG MONITORING PROCEDURE NOT PERFORMED 67 0.0373
166 MYOCARDITIS 427 0.0372
167 MAJOR DEPRESSION 272 0.0372
168 BEHAVIOUR DISORDER 200 0.0369
169 GLUCOSE TOLERANCE IMPAIRED 217 0.0367
170 ELECTROCARDIOGRAM QT PROLONGED 1318 0.0366
171 EYE MOVEMENT DISORDER 248 0.0362
172 POLYDIPSIA 142 0.0359
173 PRESCRIBED UNDERDOSE 716 0.0359
174 WEIGHT INCREASED 7918 0.0353
175 MENTAL IMPAIRMENT 854 0.0352
176 POST-TRAUMATIC STRESS DISORDER 232 0.0346
177 NORMAL NEWBORN 188 0.0346
178 LIVE BIRTH 286 0.0342
179 DISORGANISED SPEECH 63 0.0341
180 BLOOD TRIGLYCERIDES INCREASED 601 0.0340
181 BRADYPHRENIA 222 0.0340
182 IMPATIENCE 63 0.0335
183 PRESCRIBED OVERDOSE 646 0.0334
184 MONOCYTE COUNT INCREASED 121 0.0333
185 INFARCTION 227 0.0331
186 BLOOD CREATINE PHOSPHOKINASE INCREASED 950 0.0330
187 DRUG LEVEL INCREASED 522 0.0315
188 AUTONOMIC NERVOUS SYSTEM IMBALANCE 92 0.0315
189 SELF INJURIOUS BEHAVIOUR 96 0.0314
190 BRAIN INJURY 315 0.0314
191 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 62 0.0314
192 NEUTROPHIL COUNT INCREASED 320 0.0312
193 MUSCLE CONTRACTURE 63 0.0310
194 HYPERREFLEXIA 108 0.0310
195 AGITATION 2274 0.0309
196 NEGATIVE THOUGHTS 90 0.0307
197 RESTLESS LEGS SYNDROME 558 0.0307
198 ANHEDONIA 803 0.0305
199 INABILITY TO AFFORD MEDICATION 303 0.0305
200 HYPERLIPIDAEMIA 364 0.0304
201 ELECTROENCEPHALOGRAM ABNORMAL 96 0.0304
202 SUBSTANCE USE DISORDER 96 0.0301
203 MUSCLE TWITCHING 689 0.0299
204 SINUS TACHYCARDIA 424 0.0298
205 BRADYKINESIA 176 0.0298
206 AUTISM SPECTRUM DISORDER 164 0.0298
207 HYPERKINESIA 63 0.0297
208 AKINESIA 61 0.0294
209 DIABETES MELLITUS 2223 0.0291
210 FEAR OF DEATH 65 0.0289
211 POISONING DELIBERATE 274 0.0289
212 FOETAL DISTRESS SYNDROME 61 0.0287
213 SUDDEN CARDIAC DEATH 98 0.0287
214 BLEPHAROSPASM 179 0.0284
215 HYPOTHERMIA 284 0.0280
216 THERMAL BURN 199 0.0280
217 PRE-EXISTING CONDITION IMPROVED 175 0.0280
218 VENTRICULAR SEPTAL DEFECT 159 0.0277
219 SUBSTANCE ABUSE 226 0.0277
220 DIABETIC NEPHROPATHY 61 0.0277
221 SOMNAMBULISM 181 0.0275
222 DRUG SCREEN FALSE POSITIVE 76 0.0274
223 CAESAREAN SECTION 319 0.0274
224 COMA SCALE ABNORMAL 79 0.0272
225 ANORGASMIA 74 0.0272
226 FOOD CRAVING 143 0.0271
227 POTENTIATING DRUG INTERACTION 91 0.0271
228 HALLUCINATION, VISUAL 569 0.0269
229 INSURANCE ISSUE 409 0.0267
230 MUSCLE CONTRACTIONS INVOLUNTARY 93 0.0264
231 INTENTIONAL OVERDOSE 1655 0.0258
232 SOPOR 341 0.0257
233 SLOW SPEECH 62 0.0255
234 ABORTION 74 0.0253
235 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 130 0.0253
236 ANGER 853 0.0252
237 ALCOHOLISM 105 0.0245
238 BUNDLE BRANCH BLOCK RIGHT 112 0.0244
239 IRRITABILITY 1466 0.0244
240 OVERWEIGHT 130 0.0242
241 HYPERAMMONAEMIA 121 0.0242
242 AFFECT LABILITY 232 0.0241
243 DRUG INTERACTION 3811 0.0240
244 HIGH DENSITY LIPOPROTEIN DECREASED 80 0.0240
245 GRANULOCYTOPENIA 136 0.0239
246 COMMUNICATION DISORDER 90 0.0235
247 SLEEP APNOEA SYNDROME 446 0.0233
248 ABORTION INDUCED 219 0.0232
249 DYSPHEMIA 102 0.0232
250 DYSPHORIA 117 0.0231
251 RESPIRATORY DEPRESSION 283 0.0231
252 TENSION 140 0.0230
253 HICCUPS 187 0.0228
254 TREMOR 3770 0.0227
255 HYPERNATRAEMIA 113 0.0227
256 HYPERTONIA 129 0.0225
257 SYMPTOM RECURRENCE 133 0.0222
258 MATERNAL EXPOSURE DURING PREGNANCY 1943 0.0218
259 PRODUCT USE IN UNAPPROVED INDICATION 5394 0.0217
260 HYPERTHERMIA 166 0.0217
261 DYSARTHRIA 815 0.0216
262 TROPONIN INCREASED 164 0.0215
263 DECREASED INTEREST 126 0.0213
264 SCREAMING 136 0.0213
265 TONGUE DISORDER 154 0.0213
266 HALLUCINATION 1602 0.0212
267 PANIC DISORDER 82 0.0212
268 BREAST ENLARGEMENT 69 0.0210
269 FOETAL GROWTH RESTRICTION 128 0.0210
270 POLYURIA 172 0.0210
271 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 215 0.0209
272 EXPOSURE VIA BREAST MILK 83 0.0208
273 URINARY INCONTINENCE 610 0.0206
274 DELIRIUM 708 0.0204
275 DISTURBANCE IN ATTENTION 1096 0.0203
276 PREMATURE DELIVERY 323 0.0203
277 WRONG TECHNIQUE IN DRUG USAGE PROCESS 731 0.0201
278 MOOD ALTERED 547 0.0200
279 RHABDOMYOLYSIS 836 0.0200
280 INJURY 1409 0.0200
281 BLOOD CHOLESTEROL INCREASED 931 0.0200
282 MYDRIASIS 256 0.0199
283 GYNAECOMASTIA 615 0.0199
284 SUDDEN DEATH 209 0.0197
285 MIOSIS 158 0.0197
286 SUSPECTED SUICIDE 91 0.0194
287 TEARFULNESS 83 0.0193
288 CONCUSSION 149 0.0192
289 PRODUCT ADMINISTRATION INTERRUPTED 151 0.0192
290 ALTERED STATE OF CONSCIOUSNESS 416 0.0192
291 HYPERSOMNIA 549 0.0191
292 MYOCLONUS 228 0.0191
293 PREGNANCY 382 0.0191
294 FOETAL EXPOSURE DURING PREGNANCY 1541 0.0189
295 ANXIETY DISORDER 63 0.0188
296 ENERGY INCREASED 111 0.0188
297 PREMATURE LABOUR 106 0.0187
298 WOUND COMPLICATION 64 0.0186
299 DEPRESSED LEVEL OF CONSCIOUSNESS 733 0.0185
300 DEPRESSED MOOD 977 0.0185
301 ABNORMAL WEIGHT GAIN 228 0.0184
302 LOSS OF LIBIDO 166 0.0184
303 HYPERTRIGLYCERIDAEMIA 108 0.0184
304 DIABETIC KETOACIDOSIS 441 0.0183
305 DRUG LEVEL ABOVE THERAPEUTIC 84 0.0183
306 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 131 0.0183
307 ANXIETY 5199 0.0182
308 SOMNOLENCE 3644 0.0181
309 NEONATAL RESPIRATORY DISTRESS SYNDROME 64 0.0181
310 EMOTIONAL DISORDER 557 0.0180
311 COORDINATION ABNORMAL 251 0.0180
312 DEPRESSION 4086 0.0179
313 HUNGER 249 0.0179
314 BLOOD PHOSPHORUS DECREASED 65 0.0178
315 MATERNAL EXPOSURE DURING BREAST FEEDING 72 0.0177
316 ORTHOSTATIC HYPOTENSION 308 0.0177
317 RED CELL DISTRIBUTION WIDTH INCREASED 73 0.0176
318 INCONTINENCE 185 0.0175
319 PREMATURE BABY 524 0.0174
320 FEELING OF DESPAIR 81 0.0174
321 HYPERGLYCAEMIA 632 0.0173
322 LEFT VENTRICULAR DYSFUNCTION 116 0.0173
323 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 105 0.0172
324 COGNITIVE DISORDER 806 0.0172
325 SNORING 65 0.0172
326 PNEUMONIA ASPIRATION 427 0.0171
327 DISSOCIATION 131 0.0171
328 COMA 811 0.0170
329 LOW BIRTH WEIGHT BABY 135 0.0170
330 VENTRICULAR ARRHYTHMIA 62 0.0169
331 ELECTROCARDIOGRAM ABNORMAL 133 0.0169
332 CRYING 611 0.0168
333 URINARY RETENTION 557 0.0167
334 DIABETES MELLITUS INADEQUATE CONTROL 293 0.0165
335 MOOD SWINGS 523 0.0164
336 LEFT VENTRICULAR HYPERTROPHY 70 0.0163
337 SMALL FOR DATES BABY 81 0.0163
338 KETOACIDOSIS 122 0.0163
339 ERECTILE DYSFUNCTION 418 0.0163
340 COMPLETED SUICIDE 1348 0.0162
341 ATAXIA 191 0.0161
342 MOVEMENT DISORDER 516 0.0161
343 VITAMIN B12 DEFICIENCY 65 0.0160
344 ATTENTION DEFICIT HYPERACTIVITY DISORDER 67 0.0159
345 PANIC ATTACK 578 0.0158
346 HYPOKINESIA 230 0.0158
347 PHYSICAL DISABILITY 70 0.0158
348 DRUG ABUSE 1312 0.0157
349 SELF-MEDICATION 64 0.0156
350 CONGESTIVE CARDIOMYOPATHY 64 0.0153
351 MUSCLE TIGHTNESS 248 0.0153
352 FEAR 410 0.0152
353 THERAPY CHANGE 149 0.0151
354 INSOMNIA 3977 0.0149
355 HEPATIC STEATOSIS 276 0.0148
356 NIGHTMARE 512 0.0148
357 SPEECH DISORDER 772 0.0147
358 HYPERCHOLESTEROLAEMIA 142 0.0147
359 NYSTAGMUS 78 0.0147
360 NEPHROGENIC ANAEMIA 68 0.0147
361 SLEEP DISORDER 1029 0.0146
362 POOR QUALITY SLEEP 311 0.0144
363 FAECALOMA 79 0.0144
364 DISORIENTATION 571 0.0144
365 ADVERSE EVENT 1314 0.0142
366 WITHDRAWAL SYNDROME 598 0.0142
367 NEUTROPHILIA 81 0.0142
368 INITIAL INSOMNIA 146 0.0142
369 PRE-ECLAMPSIA 67 0.0141
370 SLUGGISHNESS 143 0.0140
371 GENERALISED TONIC-CLONIC SEIZURE 231 0.0139
372 MEDICATION ERROR 775 0.0139
373 LEUKOCYTOSIS 252 0.0139
374 LEUKAEMIA 130 0.0138
375 TORSADE DE POINTES 108 0.0138
376 HYPOTONIA 137 0.0137
377 HYPOTHYROIDISM 437 0.0137
378 DRUG LEVEL BELOW THERAPEUTIC 75 0.0136
379 PANIC REACTION 98 0.0136
380 THIRST 242 0.0135
381 MUSCULOSKELETAL STIFFNESS 1185 0.0135
382 ANAL INCONTINENCE 121 0.0134
383 LEUKOPENIA 669 0.0134
384 TACHYCARDIA 1188 0.0134
385 PETIT MAL EPILEPSY 68 0.0133
386 DRUG SCREEN POSITIVE 105 0.0133
387 ARTERIOSCLEROSIS CORONARY ARTERY 87 0.0131
388 CONFUSIONAL STATE 2115 0.0131
389 FORMICATION 91 0.0131
390 AMENORRHOEA 229 0.0130
391 EMOTIONAL DISTRESS 1580 0.0130
392 ABORTION SPONTANEOUS 519 0.0129
393 DECREASED ACTIVITY 139 0.0129
394 INCOHERENT 83 0.0128
395 LOW DENSITY LIPOPROTEIN INCREASED 99 0.0128
396 AMNESIA 822 0.0126
397 PANCREATITIS 666 0.0126
398 MOTOR DYSFUNCTION 128 0.0125
399 UNDERDOSE 909 0.0124
400 LIPASE INCREASED 95 0.0124
401 APPETITE DISORDER 82 0.0124
402 ASPHYXIA 100 0.0122
403 ATRIAL SEPTAL DEFECT 102 0.0122
404 BODY TEMPERATURE INCREASED 247 0.0121
405 TOXICITY TO VARIOUS AGENTS 2031 0.0120
406 PHOTOPSIA 76 0.0120
407 WHITE BLOOD CELL COUNT INCREASED 460 0.0120
408 AMMONIA INCREASED 61 0.0119
409 DYSPHAGIA 1133 0.0119
410 GRAND MAL CONVULSION 110 0.0119
411 SEIZURE 1368 0.0118
412 LYMPHOCYTE COUNT DECREASED 209 0.0118
413 VERTIGO 716 0.0117
414 LETHARGY 670 0.0116
415 CARDIOMYOPATHY 171 0.0116
416 PANCREATITIS ACUTE 260 0.0116
417 THERAPY CESSATION 593 0.0115
418 ASPIRATION 126 0.0115
419 PRODUCT PRESCRIBING ERROR 273 0.0114
420 MIDDLE INSOMNIA 214 0.0114
421 FLANK PAIN 107 0.0114
422 C-REACTIVE PROTEIN INCREASED 415 0.0114
423 SYRINGE ISSUE 198 0.0113
424 SINUS BRADYCARDIA 108 0.0112
425 FEELING JITTERY 212 0.0111
426 CEREBRAL DISORDER 82 0.0111
427 FEELING DRUNK 82 0.0110
428 MENSTRUAL DISORDER 91 0.0110
429 HYPERVENTILATION 63 0.0109
430 ILEUS 135 0.0109
431 IMPAIRED GASTRIC EMPTYING 148 0.0108
432 HAEMATOCRIT DECREASED 215 0.0108
433 CONDITION AGGRAVATED 3290 0.0108
434 MEMORY IMPAIRMENT 1476 0.0107
435 THERAPY PARTIAL RESPONDER 167 0.0107
436 NICOTINE DEPENDENCE 83 0.0107
437 VITAMIN D DEFICIENCY 104 0.0107
438 BRAIN FOG 167 0.0106
439 AGRANULOCYTOSIS 197 0.0106
440 CONVULSION 604 0.0106
441 FACIAL PARALYSIS 90 0.0105
442 APNOEA 82 0.0105
443 DYSGRAPHIA 69 0.0105
444 DRUG USE DISORDER 88 0.0105
445 TRICUSPID VALVE INCOMPETENCE 83 0.0104
446 DENTAL CARIES 115 0.0104
447 STATUS EPILEPTICUS 117 0.0103
448 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 734 0.0103
449 HYPERHIDROSIS 1328 0.0103
450 PRODUCT AVAILABILITY ISSUE 234 0.0103
451 FRUSTRATION TOLERANCE DECREASED 83 0.0103
452 COLITIS ISCHAEMIC 69 0.0102
453 NERVOUSNESS 534 0.0102
454 PARALYSIS 145 0.0101
455 MENTAL STATUS CHANGES 280 0.0101
456 POISONING 126 0.0100
457 LOSS OF CONSCIOUSNESS 1284 0.0100
458 DEMENTIA 280 0.0100
459 MUSCLE DISORDER 81 0.0100
460 CARDIO-RESPIRATORY ARREST 417 0.0100
461 IMPAIRED QUALITY OF LIFE 143 0.0099
462 EPILEPSY 304 0.0099
463 VISION BLURRED 1364 0.0099
464 SUPRAVENTRICULAR TACHYCARDIA 95 0.0099
465 IMPAIRED WORK ABILITY 211 0.0099
466 PULMONARY EMBOLISM 937 0.0098
467 SWOLLEN TONGUE 307 0.0098
468 CARDIAC FAILURE ACUTE 65 0.0097
469 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 66 0.0097
470 IMPAIRED DRIVING ABILITY 109 0.0096
471 WEIGHT FLUCTUATION 99 0.0095
472 DYSURIA 348 0.0094
473 DRUG LEVEL DECREASED 96 0.0094
474 EXPOSURE DURING PREGNANCY 582 0.0094
475 STAPHYLOCOCCAL INFECTION 308 0.0093
476 DIZZINESS POSTURAL 90 0.0093
477 MICTURITION URGENCY 106 0.0093
478 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 443 0.0092
479 FEELING ABNORMAL 2204 0.0092
480 HOSPITALISATION 1408 0.0092
481 HEPATOMEGALY 90 0.0091
482 ABNORMAL DREAMS 252 0.0091
483 ENCEPHALOPATHY 224 0.0091
484 APHASIA 273 0.0090
485 HEPATOCELLULAR INJURY 128 0.0090
486 EOSINOPHIL COUNT INCREASED 75 0.0090
487 INTERVERTEBRAL DISC DEGENERATION 83 0.0090
488 OVERDOSE 1934 0.0090
489 HEAD INJURY 283 0.0089
490 HEPATIC CYTOLYSIS 114 0.0089
491 HYPERTENSIVE CRISIS 99 0.0089
492 UNRESPONSIVE TO STIMULI 228 0.0088
493 WOUND 246 0.0088
494 OFF LABEL USE 7695 0.0088
495 SPINAL OSTEOARTHRITIS 77 0.0088
496 LIVER FUNCTION TEST ABNORMAL 254 0.0087
497 TEMPERATURE INTOLERANCE 90 0.0087
498 BLOOD ALBUMIN DECREASED 69 0.0087
499 LIGAMENT SPRAIN 86 0.0087
500 ATELECTASIS 84 0.0087
501 POLLAKIURIA 360 0.0086
502 MATERNAL DRUGS AFFECTING FOETUS 66 0.0086
503 ROAD TRAFFIC ACCIDENT 360 0.0086
504 BLOOD GLUCOSE INCREASED 1620 0.0086
505 MITRAL VALVE INCOMPETENCE 97 0.0086
506 BREAST PAIN 91 0.0085
507 BALANCE DISORDER 737 0.0085
508 CIRCULATORY COLLAPSE 145 0.0085
509 DRY MOUTH 686 0.0084
510 UNINTENDED PREGNANCY 88 0.0084
511 JOINT DISLOCATION 89 0.0084
512 ALANINE AMINOTRANSFERASE INCREASED 516 0.0084
513 BLOOD SODIUM DECREASED 158 0.0084
514 VENTRICULAR EXTRASYSTOLES 87 0.0084
515 NEUTROPHIL COUNT DECREASED 341 0.0084
516 PULMONARY CONGESTION 110 0.0083
517 HYPERTENSION 1767 0.0083
518 DRUG RESISTANCE 214 0.0083
519 SENSORY LOSS 67 0.0083
520 QUALITY OF LIFE DECREASED 111 0.0083
521 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 141 0.0082
522 TREATMENT FAILURE 681 0.0082
523 EOSINOPHILIA 144 0.0082
524 CARDIAC MURMUR 71 0.0082
525 BACK INJURY 89 0.0082
526 DRUG WITHDRAWAL SYNDROME NEONATAL 121 0.0082
527 ARRHYTHMIA 387 0.0082
528 ACTIVITIES OF DAILY LIVING IMPAIRED 161 0.0081
529 BRADYCARDIA 428 0.0081
530 CHOKING 157 0.0080
531 CHRONIC KIDNEY DISEASE 611 0.0080
532 DYSSTASIA 234 0.0080
533 PRODUCT USE ISSUE 1503 0.0080
534 PLATELET COUNT INCREASED 104 0.0080
535 STEVENS-JOHNSON SYNDROME 177 0.0080
536 HYPONATRAEMIA 448 0.0079
537 ACUTE RESPIRATORY FAILURE 153 0.0079
538 BLOOD ALKALINE PHOSPHATASE INCREASED 197 0.0079
539 GLYCOSYLATED HAEMOGLOBIN INCREASED 200 0.0079
540 HEPATIC FUNCTION ABNORMAL 295 0.0079
541 PHARYNGITIS 98 0.0079
542 THERAPY NON-RESPONDER 352 0.0078
543 SYNCOPE 781 0.0078
544 GAIT DISTURBANCE 1493 0.0078
545 NO ADVERSE EVENT 1410 0.0078
546 TENDERNESS 81 0.0078
547 PHOTOSENSITIVITY REACTION 128 0.0077
548 PYELONEPHRITIS 67 0.0077
549 TACHYPNOEA 105 0.0077
550 ERYTHEMA MULTIFORME 72 0.0077
551 HEART RATE INCREASED 763 0.0077
552 DISEASE RECURRENCE 366 0.0077
553 THERAPEUTIC RESPONSE DECREASED 466 0.0077
554 END STAGE RENAL DISEASE 139 0.0076
555 RESPIRATORY ARREST 210 0.0076
556 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 418 0.0076
557 FIBROMYALGIA 184 0.0076
558 GLOMERULAR FILTRATION RATE DECREASED 93 0.0076
559 DRUG EFFECT LESS THAN EXPECTED 111 0.0075
560 CARDIOMEGALY 92 0.0075
561 BEDRIDDEN 98 0.0074
562 DIPLOPIA 192 0.0074
563 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1498 0.0074
564 SPINAL DISORDER 70 0.0074
565 ANKLE FRACTURE 114 0.0074
566 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 189 0.0073
567 HEAD DISCOMFORT 130 0.0073
568 THERAPEUTIC RESPONSE UNEXPECTED 329 0.0073
569 HYPOGLYCAEMIA 355 0.0073
570 GAMMA-GLUTAMYLTRANSFERASE INCREASED 162 0.0073
571 CHOLECYSTECTOMY 83 0.0073
572 HAEMOLYTIC ANAEMIA 65 0.0072
573 RIB FRACTURE 149 0.0072
574 CONSTIPATION 1572 0.0072
575 GASTROENTERITIS 105 0.0072
576 INTENTIONAL PRODUCT MISUSE 627 0.0072
577 ELECTROLYTE IMBALANCE 83 0.0071
578 INTERVERTEBRAL DISC PROTRUSION 156 0.0071
579 ACCIDENT 85 0.0071
580 GENERALISED OEDEMA 88 0.0071
581 ADVERSE DRUG REACTION 636 0.0071
582 REBOUND EFFECT 80 0.0071
583 GALLBLADDER DISORDER 126 0.0071
584 SKIN INFECTION 79 0.0070
585 ASPARTATE AMINOTRANSFERASE INCREASED 374 0.0070
586 MUSCLE SPASMS 1283 0.0070
587 RESPIRATORY RATE INCREASED 62 0.0070
588 CARDIAC ARREST 574 0.0069
589 FEEDING DISORDER 141 0.0069
590 MIGRAINE 661 0.0069
591 PHOTOPHOBIA 130 0.0069
592 BLOOD UREA INCREASED 115 0.0069
593 OROPHARYNGEAL DISCOMFORT 62 0.0069
594 PRODUCT ADMINISTRATION ERROR 138 0.0068
595 JOINT STIFFNESS 179 0.0068
596 SKIN LACERATION 74 0.0068
597 DEEP VEIN THROMBOSIS 441 0.0068
598 MYOCARDIAL ISCHAEMIA 77 0.0068
599 NEUTROPENIA 911 0.0067
600 COLD SWEAT 118 0.0067
601 BLOOD THYROID STIMULATING HORMONE INCREASED 61 0.0066
602 RED BLOOD CELL COUNT DECREASED 189 0.0066
603 PERICARDITIS 111 0.0066
604 NOCTURIA 80 0.0066
605 NERVE INJURY 73 0.0066
606 DIZZINESS 3265 0.0065
607 FOOT FRACTURE 124 0.0065
608 RESPIRATORY DISTRESS 180 0.0065
609 ACUTE KIDNEY INJURY 997 0.0065
610 ACCIDENTAL OVERDOSE 238 0.0065
611 WHITE BLOOD CELL COUNT DECREASED 704 0.0065
612 FALL 2158 0.0065
613 DRUG INEFFECTIVE 8506 0.0064
614 HEART RATE DECREASED 226 0.0064
615 SEASONAL ALLERGY 91 0.0064
616 RENAL TUBULAR NECROSIS 63 0.0064
617 ACUTE RESPIRATORY DISTRESS SYNDROME 113 0.0064
618 TRANSAMINASES INCREASED 142 0.0064
619 RED BLOOD CELL SEDIMENTATION RATE INCREASED 70 0.0063
620 WEIGHT DECREASED 1764 0.0063
621 PALPITATIONS 740 0.0063
622 THERAPEUTIC RESPONSE SHORTENED 209 0.0063
623 CYANOSIS 99 0.0063
624 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1134 0.0063
625 HYPOTENSION 1260 0.0063
626 SCRATCH 66 0.0063
627 MALNUTRITION 70 0.0063
628 CHEST PAIN 1157 0.0062
629 TOOTH LOSS 129 0.0062
630 OEDEMA PERIPHERAL 756 0.0062
631 DRUG DOSE OMISSION 1021 0.0062
632 FACE OEDEMA 104 0.0062
633 BACK DISORDER 100 0.0061
634 DRUG PRESCRIBING ERROR 118 0.0061
635 HIATUS HERNIA 79 0.0061
636 OXYGEN SATURATION DECREASED 342 0.0061
637 TOOTHACHE 110 0.0061
638 VOMITING 2855 0.0061
639 CYST 75 0.0060
640 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 176 0.0060
641 HYPOKALAEMIA 276 0.0060
642 IRRITABLE BOWEL SYNDROME 128 0.0060
643 GASTROOESOPHAGEAL REFLUX DISEASE 477 0.0059
644 SENSORY DISTURBANCE 95 0.0059
645 LIVER INJURY 145 0.0059
646 INTESTINAL OBSTRUCTION 222 0.0059
647 NECK PAIN 329 0.0059
648 BLOOD PRESSURE ABNORMAL 117 0.0059
649 PRESYNCOPE 143 0.0059
650 CARPAL TUNNEL SYNDROME 82 0.0058
651 CELLULITIS 291 0.0058
652 PALLOR 157 0.0058
653 EAR PAIN 112 0.0058
654 SARS-COV-2 TEST POSITIVE 76 0.0057
655 DIALYSIS 81 0.0057
656 CHOLELITHIASIS 187 0.0057
657 BLOOD TEST ABNORMAL 80 0.0057
658 BLOOD CALCIUM DECREASED 64 0.0057
659 RENAL FAILURE 754 0.0057
660 RETCHING 121 0.0057
661 FATIGUE 4380 0.0056
662 TOOTH FRACTURE 62 0.0056
663 HEART RATE IRREGULAR 127 0.0056
664 DISSEMINATED INTRAVASCULAR COAGULATION 79 0.0056
665 OSTEOPENIA 85 0.0056
666 FEELING HOT 342 0.0056
667 TRANSIENT ISCHAEMIC ATTACK 188 0.0056
668 HEPATIC ENZYME INCREASED 379 0.0056
669 MUSCULAR WEAKNESS 629 0.0055
670 EJECTION FRACTION DECREASED 86 0.0055
671 DEHYDRATION 737 0.0055
672 ANGINA PECTORIS 158 0.0055
673 ANOREXIA 71 0.0055
674 EYE DISORDER 181 0.0055
675 METABOLIC ACIDOSIS 176 0.0055
676 MENSTRUATION IRREGULAR 147 0.0055
677 BLOOD POTASSIUM DECREASED 165 0.0055
678 VISUAL IMPAIRMENT 680 0.0055
679 NERVOUS SYSTEM DISORDER 171 0.0055
680 HYPOPHAGIA 140 0.0055
681 MYALGIA 931 0.0055
682 ULCER 87 0.0055
683 BLOOD GLUCOSE ABNORMAL 101 0.0055
684 VISUAL ACUITY REDUCED 181 0.0054
685 DRUG WITHDRAWAL SYNDROME 478 0.0054
686 BLOOD CREATININE INCREASED 355 0.0054
687 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 282 0.0054
688 SCIATICA 86 0.0054
689 BRONCHITIS 398 0.0054
690 BLOOD PRESSURE FLUCTUATION 129 0.0054
691 DRUG ADMINISTRATION ERROR 164 0.0053
692 BLOOD BILIRUBIN INCREASED 144 0.0053
693 HYPOAESTHESIA 795 0.0053
694 DRUG ERUPTION 94 0.0053
695 MALAISE 2325 0.0053
696 DRUG INTOLERANCE 512 0.0053
697 GAIT INABILITY 177 0.0053
698 TUBULOINTERSTITIAL NEPHRITIS 99 0.0053
699 PHARYNGEAL OEDEMA 81 0.0053
700 RENAL DISORDER 245 0.0053
701 BLOOD PRESSURE DECREASED 349 0.0052
702 HAEMATEMESIS 133 0.0052
703 BLOOD PRESSURE INCREASED 802 0.0052
704 HEADACHE 3280 0.0052
705 THROAT TIGHTNESS 141 0.0052
706 ASTHMA 589 0.0052
707 VENTRICULAR TACHYCARDIA 86 0.0052
708 NEUROPATHY PERIPHERAL 495 0.0052
709 LIMB DISCOMFORT 161 0.0052
710 THYROID DISORDER 80 0.0052
711 NAUSEA 4107 0.0052
712 MULTIPLE FRACTURES 85 0.0052
713 CARDIOGENIC SHOCK 74 0.0052
714 ISCHAEMIC STROKE 92 0.0051
715 LOWER LIMB FRACTURE 99 0.0051
716 ADRENAL INSUFFICIENCY 62 0.0051
717 PERIPHERAL COLDNESS 70 0.0051
718 MENORRHAGIA 100 0.0051
719 PRODUCT SUBSTITUTION ISSUE 293 0.0051
720 CONJUNCTIVITIS 94 0.0051
721 SMALL INTESTINAL OBSTRUCTION 62 0.0050
722 TOOTH INFECTION 66 0.0050
723 TOXIC EPIDERMAL NECROLYSIS 76 0.0050
724 EAR INFECTION 133 0.0050
725 SURGERY 293 0.0050
726 GLAUCOMA 96 0.0050
727 OEDEMA 270 0.0050
728 URINARY TRACT INFECTION 846 0.0050
729 DRUG EFFECT INCOMPLETE 179 0.0049
730 PRODUCT PRESCRIBING ISSUE 107 0.0049
731 OSTEOPOROSIS 202 0.0049
732 DRUG DISPENSING ERROR 75 0.0049
733 RASH GENERALISED 127 0.0049
734 GASTRITIS 129 0.0049
735 CONTUSION 471 0.0049
736 DYSPHONIA 286 0.0049
737 UPPER LIMB FRACTURE 96 0.0048
738 NASAL CONGESTION 283 0.0048
739 SINUS CONGESTION 65 0.0048
740 OSTEOARTHRITIS 203 0.0048
741 RESPIRATORY FAILURE 348 0.0048
742 HYPERTHYROIDISM 69 0.0048
743 PAIN IN JAW 135 0.0048
744 MUSCULOSKELETAL DISCOMFORT 82 0.0048
745 DECREASED APPETITE 1106 0.0048
746 ALOPECIA 935 0.0048
747 FRACTURE 90 0.0047
748 DYSPEPSIA 466 0.0047
749 APHONIA 66 0.0047
750 ABSCESS 75 0.0047
751 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 334 0.0047
752 HEPATITIS 120 0.0047
753 ORAL PAIN 105 0.0047
754 ASTHENIA 1762 0.0047
755 PAIN 2861 0.0047
756 CHOLESTASIS 89 0.0046
757 LIMB INJURY 125 0.0046
758 PYREXIA 1592 0.0046
759 DISCOMFORT 280 0.0046
760 BLINDNESS 187 0.0046
761 PERIPHERAL SWELLING 704 0.0046
762 DRY EYE 228 0.0046
763 RENAL IMPAIRMENT 382 0.0045
764 RENAL INJURY 135 0.0045
765 JOINT INJURY 96 0.0045
766 LOWER RESPIRATORY TRACT INFECTION 204 0.0045
767 PRODUCT DOSE OMISSION IN ERROR 127 0.0045
768 BACK PAIN 1038 0.0045
769 FEELING COLD 124 0.0044
770 NIGHT SWEATS 143 0.0044
771 UNEVALUABLE EVENT 334 0.0044
772 OROPHARYNGEAL PAIN 408 0.0044
773 TOOTH DISORDER 98 0.0044
774 PRODUCT DOSE OMISSION ISSUE 1295 0.0044
775 CARDIAC DISORDER 411 0.0044
776 KIDNEY INFECTION 86 0.0044
777 LYMPHADENOPATHY 155 0.0044
778 DRUG EFFECT DECREASED 235 0.0044
779 TINNITUS 200 0.0043
780 LIVER DISORDER 193 0.0043
781 ILLNESS 446 0.0043
782 GASTROENTERITIS VIRAL 78 0.0043
783 HYPOAESTHESIA ORAL 65 0.0043
784 JAUNDICE 116 0.0043
785 SHOCK 99 0.0043
786 NEPHROLITHIASIS 196 0.0043
787 PULMONARY HYPERTENSION 89 0.0043
788 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 78 0.0043
789 HYPOXIA 149 0.0042
790 PULMONARY OEDEMA 189 0.0042
791 ABDOMINAL PAIN 980 0.0042
792 INTENTIONAL DOSE OMISSION 120 0.0042
793 DRUG-INDUCED LIVER INJURY 132 0.0042
794 BLOOD PRESSURE SYSTOLIC INCREASED 82 0.0042
795 THERAPY INTERRUPTED 300 0.0042
796 THROMBOCYTOPENIA 469 0.0042
797 BLOOD POTASSIUM INCREASED 68 0.0042
798 BLOOD URINE PRESENT 79 0.0042
799 SCAR 71 0.0041
800 CHEST DISCOMFORT 424 0.0041
801 RHINORRHOEA 267 0.0041
802 INTENTIONAL PRODUCT USE ISSUE 361 0.0041
803 PARAESTHESIA 648 0.0041
804 HAEMORRHOIDS 80 0.0041
805 ABASIA 101 0.0041
806 BLOOD GLUCOSE DECREASED 194 0.0040
807 CONTRAINDICATED PRODUCT ADMINISTERED 122 0.0040
808 PERICARDIAL EFFUSION 93 0.0040
809 GENERAL PHYSICAL HEALTH DETERIORATION 464 0.0040
810 TENDONITIS 62 0.0040
811 PNEUMONIA 1296 0.0040
812 EYE PAIN 223 0.0039
813 ABDOMINAL DISTENSION 410 0.0039
814 CYSTITIS 125 0.0039
815 DYSPNOEA 2219 0.0039
816 PANCYTOPENIA 219 0.0039
817 BLOOD LACTATE DEHYDROGENASE INCREASED 62 0.0039
818 UPPER RESPIRATORY TRACT INFECTION 180 0.0039
819 HEPATIC FAILURE 117 0.0039
820 BURNING SENSATION 272 0.0039
821 HERNIA 75 0.0039
822 RESPIRATORY DISORDER 116 0.0039
823 PAIN IN EXTREMITY 1142 0.0039
824 GASTRIC DISORDER 133 0.0039
825 GASTROINTESTINAL DISORDER 347 0.0039
826 HAEMOGLOBIN DECREASED 396 0.0039
827 SWELLING FACE 251 0.0039
828 VAGINAL HAEMORRHAGE 167 0.0038
829 ABDOMINAL PAIN UPPER 791 0.0038
830 COAGULOPATHY 64 0.0038
831 VIRAL INFECTION 127 0.0038
832 SKIN DISCOLOURATION 175 0.0038
833 RESPIRATORY TRACT INFECTION 99 0.0038
834 THERAPEUTIC PRODUCT EFFECT DECREASED 170 0.0038
835 HEPATIC CIRRHOSIS 71 0.0038
836 LIVER FUNCTION TEST INCREASED 81 0.0038
837 METRORRHAGIA 64 0.0037
838 SINUS DISORDER 74 0.0037
839 DRUG EXPOSURE DURING PREGNANCY 127 0.0037
840 HAEMATOMA 96 0.0037
841 INCORRECT DOSE ADMINISTERED 845 0.0037
842 SEPSIS 409 0.0037
843 INFLUENZA LIKE ILLNESS 301 0.0037
844 HYPERKALAEMIA 128 0.0036
845 PLATELET COUNT DECREASED 387 0.0036
846 CARDIOVASCULAR DISORDER 92 0.0036
847 NEURALGIA 88 0.0036
848 ABDOMINAL DISCOMFORT 605 0.0036
849 MOBILITY DECREASED 259 0.0036
850 CEREBRAL INFARCTION 88 0.0036
851 MUSCULOSKELETAL PAIN 188 0.0036
852 FLATULENCE 203 0.0036
853 ARTHRITIS 281 0.0036
854 HYPERSENSITIVITY 662 0.0036
855 EPISTAXIS 265 0.0035
856 CHILLS 415 0.0035
857 NEEDLE ISSUE 103 0.0035
858 CHROMATURIA 79 0.0035
859 RASH 1524 0.0035
860 DRUG DEPENDENCE 560 0.0035
861 GASTRIC ULCER 66 0.0035
862 CEREBROVASCULAR ACCIDENT 588 0.0035
863 INFLUENZA 387 0.0035
864 RENAL FAILURE ACUTE 147 0.0035
865 THROMBOSIS 278 0.0035
866 LIP SWELLING 115 0.0034
867 MULTIPLE SCLEROSIS 165 0.0034
868 SWELLING 321 0.0034
869 SINUSITIS 349 0.0034
870 DEAFNESS 88 0.0034
871 INTENTIONAL DRUG MISUSE 70 0.0033
872 NASOPHARYNGITIS 617 0.0033
873 SKIN DISORDER 111 0.0033
874 KNEE ARTHROPLASTY 70 0.0033
875 ARTHRALGIA 1382 0.0033
876 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 112 0.0033
877 DIARRHOEA 2140 0.0033
878 THROAT IRRITATION 148 0.0033
879 SEPTIC SHOCK 143 0.0033
880 MULTIPLE ORGAN DYSFUNCTION SYNDROME 93 0.0033
881 PRODUCTIVE COUGH 156 0.0033
882 WHEEZING 193 0.0033
883 INJECTION SITE MASS 120 0.0032
884 SPINAL FRACTURE 65 0.0032
885 CARDIAC FAILURE 259 0.0032
886 LOCALISED INFECTION 78 0.0032
887 MYOCARDIAL INFARCTION 562 0.0032
888 CLOSTRIDIUM DIFFICILE INFECTION 70 0.0032
889 PERITONITIS 66 0.0032
890 BLISTER 177 0.0031
891 PRODUCT DOSE OMISSION 205 0.0031
892 SKIN LESION 86 0.0031
893 ATRIAL FIBRILLATION 305 0.0031
894 LACTIC ACIDOSIS 101 0.0031
895 LUNG DISORDER 152 0.0031
896 ILL-DEFINED DISORDER 188 0.0031
897 FLUID RETENTION 156 0.0031
898 INFLAMMATION 158 0.0031
899 FUNGAL INFECTION 102 0.0031
900 COUGH 854 0.0030
901 MOUTH ULCERATION 64 0.0030
902 FREQUENT BOWEL MOVEMENTS 82 0.0030
903 INFECTION 437 0.0030
904 CARDIAC FAILURE CONGESTIVE 241 0.0030
905 ANAPHYLACTIC REACTION 165 0.0030
906 MUCOSAL INFLAMMATION 78 0.0030
907 ANAEMIA 566 0.0030
908 RASH MACULO-PAPULAR 66 0.0030
909 ECZEMA 154 0.0029
910 ANGIOEDEMA 130 0.0029
911 HAEMATOCHEZIA 162 0.0029
912 HYPOACUSIS 124 0.0029
913 HOT FLUSH 215 0.0028
914 BONE PAIN 167 0.0028
915 PRODUCT DISPENSING ERROR 62 0.0028
916 MULTIPLE SCLEROSIS RELAPSE 195 0.0028
917 RASH PRURITIC 154 0.0028
918 CATARACT 169 0.0028
919 FLUSHING 287 0.0028
920 JOINT SWELLING 340 0.0028
921 LACRIMATION INCREASED 85 0.0028
922 DYSGEUSIA 209 0.0028
923 AGEUSIA 70 0.0028
924 ACUTE MYOCARDIAL INFARCTION 82 0.0028
925 DEPENDENCE 152 0.0028
926 COVID-19 486 0.0028
927 INCORRECT DRUG ADMINISTRATION DURATION 77 0.0027
928 GLOSSODYNIA 61 0.0027
929 PRODUCT STORAGE ERROR 238 0.0027
930 HAEMORRHAGE 280 0.0027
931 RECTAL HAEMORRHAGE 115 0.0027
932 URTICARIA 447 0.0027
933 DYSPNOEA EXERTIONAL 98 0.0026
934 IMPAIRED HEALING 85 0.0026
935 PSORIATIC ARTHROPATHY 105 0.0026
936 EYE IRRITATION 148 0.0026
937 ABDOMINAL PAIN LOWER 65 0.0026
938 ARTHROPATHY 142 0.0026
939 HAEMOPTYSIS 71 0.0025
940 PRURITUS 971 0.0025
941 ACNE 189 0.0025
942 HAEMATURIA 85 0.0025
943 STOMATITIS 150 0.0025
944 RASH ERYTHEMATOUS 118 0.0025
945 RASH MACULAR 86 0.0025
946 EYE SWELLING 91 0.0024
947 INTERNATIONAL NORMALISED RATIO INCREASED 69 0.0024
948 SKIN EXFOLIATION 204 0.0024
949 PLEURAL EFFUSION 146 0.0024
950 ERYTHEMA 493 0.0024
951 OCULAR HYPERAEMIA 113 0.0024
952 EXPIRED PRODUCT ADMINISTERED 79 0.0024
953 BONE DENSITY DECREASED 73 0.0023
954 INJECTION SITE PAIN 709 0.0023
955 LABORATORY TEST ABNORMAL 68 0.0023
956 HIP FRACTURE 73 0.0023
957 PRODUCT QUALITY ISSUE 308 0.0023
958 CORONARY ARTERY DISEASE 68 0.0022
959 DIVERTICULITIS 62 0.0022
960 FEMUR FRACTURE 68 0.0022
961 COLITIS 83 0.0022
962 DEATH 1850 0.0021
963 PSORIASIS 280 0.0021
964 GASTROINTESTINAL HAEMORRHAGE 176 0.0021
965 RHEUMATOID ARTHRITIS 234 0.0021
966 NEOPLASM MALIGNANT 137 0.0021
967 HERPES ZOSTER 113 0.0020
968 CEREBRAL HAEMORRHAGE 69 0.0019
969 DERMATITIS ATOPIC 100 0.0019
970 SYSTEMIC LUPUS ERYTHEMATOSUS 67 0.0019
971 INTERSTITIAL LUNG DISEASE 91 0.0019
972 DRY SKIN 245 0.0018
973 INJECTION SITE REACTION 126 0.0018
974 NEOPLASM PROGRESSION 62 0.0018
975 COLITIS ULCERATIVE 75 0.0017
976 INFUSION RELATED REACTION 109 0.0016
977 INJECTION SITE SWELLING 126 0.0016
978 EXTRA DOSE ADMINISTERED 65 0.0016
979 DEVICE ISSUE 142 0.0016
980 DEVICE BREAKAGE 63 0.0016
981 DEVICE DISLOCATION 65 0.0015
982 BREAST CANCER 139 0.0015
983 SKIN IRRITATION 67 0.0015
984 DISEASE PROGRESSION 173 0.0015
985 INJECTION SITE BRUISING 116 0.0015
986 INJECTION SITE ERYTHEMA 163 0.0013
987 FEBRILE NEUTROPENIA 85 0.0013
988 SKIN BURNING SENSATION 88 0.0012
989 INJECTION SITE HAEMORRHAGE 95 0.0012
990 INJECTION SITE PRURITUS 79 0.0012
991 DEVICE MALFUNCTION 69 0.0010
992 ACCIDENTAL EXPOSURE TO PRODUCT 98 0.0009